In A Nutshell An existing osteoporosis medication (PTH) reduced chronic back pain in three mouse models of spinal ...

First publication of clinical efficacy data for PP353, in development for chronic Low Back PainTrial demonstrated that PP353 delivers clinically ...

Back pain is one of the most common of all health complaints and, for nearly six million people, the pain is constant and ...

Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort ...

It's not just Botox and IV therapy. The reversal of a COVID rule could upend family and maternal care, mental healthcare ...

A tangle of emotions around aging—and the shame of doing something about it—bled into an eyebrow-raising covert operation.

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk's shares tumbled as much as 20% ...

The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is ...

A WOMAN has shared an urgent Mounjaro warning after she experienced “violent” side effects within just 24 hours of taking her ...

A woman who almost died after unknowingly injecting herself with "fake Ozempic" she bought on Facebook has revealed the ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...